[1]
Dhanya, T.H., Gangadhar, R. and Subha, N. 2017. Clinical and economic outcomes of risperidone versus clozapine in the treatment of chronic schizophrenia. International Journal of Basic & Clinical Pharmacology. 4, 6 (Jan. 2017), 1080–1085. DOI:https://doi.org/10.18203/2319-2003.ijbcp20151335.